Ionis Pharmaceuticals's total assets for Q2 2026 were $2.99B, a decrease of -13.20% from the previous quarter. MX:IONS total liabilities were $2.56B for the fiscal quarter, a -13.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.